Robot maker · registered
ForSight Robotics
JASPER platform (formerly ORYOM): 14-DOF ophthalmic microsurgical robot integrating AI-based algorithms, advanced computer vision, miniaturized mechanics, and stereoscopic imaging; designed for complete cataract surgery and widespread eye diseases; motion scaling and surgeon-assist throughout procedure; active US clinical trial (NCT07468409); achieved world's first fully robot-assisted cataract surgery in a human patient (April 2026).
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
JASPER Platform
- 14-DOF microsurgical robot; AI-based algorithms, advanced computer vision, and miniaturized mechanics engineered for precise, consistent ophthalmic procedures
Vendor-stated degrees of freedom and autonomy approach for the JASPER (formerly ORYOM) ophthalmic surgical platform
Claim source - Performed world's first fully robot-assisted cataract surgery in a human patient without general anesthesia (April 2026, clinical study setting)
Independently reported first-in-human milestone for the JASPER platform, confirming hardware capability in an active clinical study
Claim source
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Series B
Adani Group, Dr. Fred Moll, Eclipse, Reiya Ventures
Round sourceSeries A
Adani Group, Eclipse Ventures, Ljungstrom family office, Mithril Capital Management, Precision Capital, Provenio Capital, Reiya Ventures
Round sourceSeed
Eclipse Ventures, Mithril Capital Management
Round sourceCompany timeline
Milestones and announcements
Source ledger
7 unique public sources